Onderneming Endo Health Solutions Inc Nasdaq
Aandelen
US29264F2056
Holdingvennootschappen
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Branded Pharmaceuticals
42,7
%
| 851 | 36,7 % | 859 | 42,7 % | +0,93% |
Generic Pharmaceuticals
32,3
%
| 795 | 34,3 % | 650 | 32,3 % | -18,24% |
Sterile Injectables
21,4
%
| 590 | 25,4 % | 430 | 21,4 % | -27,15% |
International Pharmaceuticals
3,6
%
| 83 | 3,6 % | 73 | 3,6 % | -12,25% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
96,4
%
| 2 236 | 96,4 % | 1 939 | 96,4 % | -13,29% |
International
3,6
%
| 83 | 3,6 % | 73 | 3,6 % | -12,25% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Blaise A Coleman
CEO | Chief Executive Officer | 50 | 01-01-15 |
Mark Bradley
DFI | Director of Finance/CFO | 54 | 01-01-07 |
Cheryl Stouch
CTO | Chief Tech/Sci/R&D Officer | - | - |
Susan Williamson
CMP | Compliance Officer | - | 01-04-18 |
James Tursi
CTO | Chief Tech/Sci/R&D Officer | 59 | 18-01-22 |
Laure E. Park
IRC | Investor Relations Contact | - | 02-08-18 |
Michael Randolph
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 01-06-22 | |
Frank B. Raciti
AUD | Comptroller/Controller/Auditor | - | - |
Tracy Basso
HRO | Human Resources Officer | - | 01-07-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Hyatt
BRD | Director/Board Member | 78 | 01-02-14 |
Director/Board Member | 77 | 28-02-14 | |
Jennifer Chao
BRD | Director/Board Member | 54 | 17-02-21 |
Shane Cooke
BRD | Director/Board Member | 61 | 29-07-14 |
Mark Barberio
CHM | Chairman | 61 | 19-02-20 |
Nancy Hutson
BRD | Director/Board Member | 74 | 28-02-14 |
Blaise A Coleman
CEO | Chief Executive Officer | 50 | 01-01-15 |
Director/Board Member | 59 | 29-07-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 235 219 612 | 233 686 398 ( 99,35 %) | 0 | 99,35 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Par Active Technologies Pvt Ltd.
Par Active Technologies Pvt Ltd. Pharmaceuticals: MajorHealth Technology Par Active Technologies Pvt Ltd. manufactures pharmaceutical preparations. The company is headquartered in Kancheepuram, India. |
Pharmaceuticals: Major
|
Par Biosciences Pvt Ltd.
| |
Endo Luxembourg Finance Company I SARL
|
Finance/Rental/Leasing
|
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+178,17% | 6,17 mld. | |
-6,60% | 998 mln. | |
+2,00% | 982 mln. | |
+41,91% | 872 mln. | |
+22,85% | 803 mln. | |
+1,82% | 663 mln. | |
+21,31% | 601 mln. | |
-.--% | 600 mln. | |
-2,15% | 596 mln. |
- Beurs
- Aandelen
- Koers ENDPQ
- Koers
- Onderneming Endo Health Solutions Inc